StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) bonds

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.08MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

NRX Pharmaceuticals reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in NRX Pharmaceuticals's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Anson Convertible Notes
Convertible
–$16.31M$0
Anson First Tranche Notes
Convertible at $2 a share
6.00%$5.44M–
Anson Note––$0
Anson Second Tranche Notes
Convertible at $2 a share
–$5.40M–
Anson Third Tranche Notes
Convertible at $4 a share
–$5.44M–
Streeterville Convertible Note
Convertible
–$11.02M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?